(Q37210118)

19 August 2017

title

Blood pressure changes during clozapine or olanzapine treatment in Korean schizophrenic patients (English)

1 reference

19 August 2017

0 references

4

Bo-Hyun Yoon

1 reference

19 August 2017

5

Won-Myong Bahk

1 reference

19 August 2017

1

Young Sup Woo

1 reference

19 August 2017

Won Kim

2

1 reference

19 August 2017

Jeong-Ho Chae

series ordinal

3

1 reference

19 August 2017

publication date

1 January 2009

1 reference

World Journal of Biological Psychiatry

19 August 2017

published in

1 reference

19 August 2017

volume

10

1 reference

19 August 2017

issue

4 Pt 2

1 reference

19 August 2017

page(s)

420-425

1 reference

Clozapine. A novel antipsychotic agent

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F15622970801910399

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970801910399

Association of autonomic dysfunction and clozapine. Heart rate variability and risk for sudden death in patients with schizophrenia on long-term psychotropic medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970801910399

Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970801910399

Differential metabolic effects of antipsychotic treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970801910399

Schizophrenia and increased risks of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970801910399

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970801910399

Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970801910399

Actual Causes of Death in the United States, 2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970801910399

Autonomic responses of blood vessels and sweat glands in patients with schizophrenia treated with olanzapine or clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970801910399

Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970801910399

Bodyweight gain associated with atypical antipsychotics: epidemiology and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970801910399

Physical consequences of schizophrenia and its treatment: the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970801910399

Weight and blood pressure. Findings in hypertension screening of 1 million Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970801910399

10.1080/15622970801910399

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference